Shanghai Jinhe Bio-Technology Co., Ltd.is a high Bio-Tech private enterprise dedicated to developing, manufacturing and marketing Anti-Cancer APIs and their intermediates.

Jinhe was established in March 2002. Based on the R&D achievement of FUDAN university, at the beginning it launched the international business of processing Paclitaxel API. After several years of development, we become the largest processor on Taxus biomass in China. Furthermore, we successfully developed Docetaxel Anhydrous( Trihydrate), Irinotecan HCL Trihydrate, Etoposide and other products, developing Anti-cancer products from nature extracting to semi-synthetical Anti-cancer products. In recent two years we successfully developed Fludarabine Phosphate, Palonosetron Hydrochloride among others，products portfolio extending to broad-spectrum Anti-cancer drugs....